Dr Carolyn Taylor
Carolyn Taylor
Letters after your name
Clinical Research Fellow and Honorary Consultant Oncologist
Carolyn Taylor is a consultant clinical oncologist and researcher into the late effects of cancer treatments. She studied medicine at Oxford University. Her clinical training was in general medicine and then clinical oncology. She gained Fellowship of the Royal College of Radiologists in 2004.
Since then she has worked as a clinical research fellow at the Clinical Trial Service Unit, doing research alongside clinical work. She completed her DPhil on the risk of heart disease after breast cancer radiotherapy in 2008. She now continues to research the late effects of cancer treatments and works in the clinic with childhood cancer survivors.
Recent publications
-
Authors' reply to Oke and Welch.
Journal article
Darby SC. et al, (2023), BMJ, 382
-
Should patients requiring radiotherapy for breast cancer be treated with proton beam therapy?
Journal article
Kirby AM. et al, (2023), BMJ, 381
-
Proton Beam Therapy for Early Breast Cancer: A Systematic Review and Meta-analysis of Clinical Outcomes.
Journal article
Holt F. et al, (2023), Int J Radiat Oncol Biol Phys
-
Anthracycline and taxane containing chemotherapy for early-stage operable breast cancer: meta-analyses of 100,000 women in 86 randomised trials
Journal article
Taylor CAROLYN. et al, (2023), The Lancet
-
Adjuvant and neoadjuvant breast cancer treatments: A systematic review of their effects on mortality.
Journal article
Kerr AJ. et al, (2022), Cancer Treat Rev, 105